RKDA 📈 Arcadia Biosciences - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0390142042
RKDA: Wheat, Water, Pain Relief, Food, Beverages
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Web URL: https://www.arcadiabio.com
Additional Sources for RKDA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RKDA Stock Overview
| Market Cap in USD | 8m |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| GiC Sub-Industry | Agricultural Products & Services |
| IPO / Inception | 2015-05-15 |
RKDA Stock Ratings
| Growth 5y | -76.1% |
| Fundamental | -46.2% |
| Dividend | - |
| Rel. Strength Industry | 775 |
| Analysts | 4.5/5 |
| Fair Price Momentum | 4.52 USD |
| Fair Price DCF | - |
RKDA Dividends
No Dividends PaidRKDA Growth Ratios
| Growth Correlation 3m | 47.3% |
| Growth Correlation 12m | 52.8% |
| Growth Correlation 5y | -96.8% |
| CAGR 5y | -51.37% |
| CAGR/Mean DD 5y | -0.67 |
| Sharpe Ratio 12m | 1.05 |
| Alpha | 86.74 |
| Beta | 1.12 |
| Volatility | 82.52% |
| Current Volume | 56.2k |
| Average Volume 20d | 3711.7k |
What is the price of RKDA stocks?
As of December 22, 2024, the stock is trading at USD 6.35 with a total of 56,193 shares traded.
Over the past week, the price has changed by -1.27%, over one month by +119.01%, over three months by +112.29% and over the past year by +118.63%.
As of December 22, 2024, the stock is trading at USD 6.35 with a total of 56,193 shares traded.
Over the past week, the price has changed by -1.27%, over one month by +119.01%, over three months by +112.29% and over the past year by +118.63%.
Is Arcadia Biosciences a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Arcadia Biosciences (NASDAQ:RKDA) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -46.23 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RKDA as of December 2024 is 4.52. This means that RKDA is currently overvalued and has a potential downside of -28.82%.
Probably not. Based on ValueRay Fundamental Analyses, Arcadia Biosciences (NASDAQ:RKDA) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -46.23 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RKDA as of December 2024 is 4.52. This means that RKDA is currently overvalued and has a potential downside of -28.82%.
Is RKDA a buy, sell or hold?
Arcadia Biosciences has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy RKDA.
Arcadia Biosciences has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy RKDA.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for RKDA stock price target?
According to ValueRays Forecast Model, RKDA Arcadia Biosciences will be worth about 5 in December 2025. The stock is currently trading at 6.35. This means that the stock has a potential downside of -20.79%.
According to ValueRays Forecast Model, RKDA Arcadia Biosciences will be worth about 5 in December 2025. The stock is currently trading at 6.35. This means that the stock has a potential downside of -20.79%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 9 | 41.7% |
| Analysts Target Price | 15 | 136.2% |
| ValueRay Target Price | 5 | -20.8% |